Set yourself up for success with the world’s largest range of quality, precision antibodies and assays. As the proud winners of the 2024 CiteAb award for Supplier Succeeding in IHC, we’re committed to providing you with the best reagents for biomarker discovery and validation.

 

Our recombinant antibody technology means our reagents work first time, every time, and over time, giving your research the reliable tools it deserves.

 

Browse our curated portfolio of extensively validated antibodies and assays, with antibodies to over 90% of key targets in major glioblastoma pathways– including EGF, VEGF, MAPK, Wnt, NFKB, and PI3K/AkT/MTOR – all in one place.